Phototherapy Equipment Market - Strategic Insights and Forecasts (2026-2031)

The Phototherapy Equipment Market is projected to register a strong CAGR during the 2026-2031 forecast period. This growth is fundamentally anchored in the rising global burden of neonatal jaundice, affecting approximately 60% of full-term and 80% of preterm infants, alongside the increasing prevalence of chronic skin disorders like psoriasis and vitiligo.

Technological evolution is significantly shaping the market through the integration of semiconductor-based light sources like LEDs, which allow for narrow-band emission, maximizing therapeutic outcomes while minimizing DNA damage. This shift also extends light-source lifespans from 2,000 to over 50,000 hours. Furthermore, the market is responding to a sustainability transition by phasing out mercury-containing fluorescent lamps in alignment with international environmental protocols.

North America is expected to maintain its lead in the Phototherapy Equipment Market. This dominance is attributed to the region's advanced diagnostic infrastructure and favorable reimbursement codes, such as CPT codes in the U.S., which support both clinical and home-based phototherapy applications.

Stringent regulatory compliance costs, driven by the enforcement of the EU Medical Device Regulation (MDR) and FDA Class II requirements, are significantly increasing the cost of market entry. This regulatory pressure is a key highlight, forcing smaller manufacturers to consolidate or exit the market, thereby influencing the competitive landscape.

The market is witnessing a significant shift towards point-of-care and home-based treatment, driven by rising patient preference for chronic disease management outside clinical settings. This trend is fostering the development of portable, homecare-compatible devices, including 'smart' handheld and wearable devices with remote monitoring capabilities.

Hospitals and Clinics remain the primary end-users, largely due to the high volume of neonatal jaundice cases requiring immediate, high-intensity intervention. However, there is a growing emphasis on decentralizing the market from large-scale hospital installations toward portable, homecare-compatible devices, signaling a shift to home-based care for chronic disease management.